Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer Research Communications|July 26, 2024
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain MetastasesJulia Gellert, Dennis A Agardy, Swaminathan Kumar, et al.Cancer Letters|July 27, 2025
Neoadjuvant immune checkpoint inhibition improves protection against hepatic melanoma metastasisSebastian A Wohlfeil, Céline Weller, Bianca Dietsch, et al.Journal of Cancer Research and Clinical Oncology|November 1, 2025
Computational identification of cross-reactive TCR epitopes with ARDitoxVictor Murcia Pienkowski, Tamara Boschert, Piotr Skoczylas, et al.Science Advances|February 2, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patientTamara Boschert, Kristina Kromer, Taga Lerner, et al.Neuro-Oncology|September 16, 2023
NLGN4X TCR transgenic T cells to treat gliomasChristoper Krämer, Michael Kilian, Yu-Chan Chih, et al.Neurological Research and Practice|October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasNiklas Grassl, Katharina Sahm, Heike Süße, et al.Journal for Immunotherapy of Cancer|September 22, 2025
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancerKatharina Lindner, Saskia R Stange, Julian Benedikt Hlawatsch, et al.Science Advances|February 2, 2024
T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discoveryMiray Cetin, Veronica Pinamonti, Theresa Schmid, et al.Nature Medicine|September 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline gliomaNiklas Grassl, Isabel Poschke, Katharina Lindner, et al.Cancer Discovery|May 4, 2021
Inhibition of CDK4/6 Promotes CD8 T-cell Memory FormationMax Heckler, Lestat R Ali, Eleanor Clancy-Thompson, et al.Pageof 1